← Back to headlines
Novartis Faces Increased Competition from Generic Drugs
Pharmaceutical giant Novartis is experiencing pressure from the rise of copycat drugs, impacting its market share and financial performance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
